KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Return on Sales (2016 - 2025)

Historic Return on Sales for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to 0.22%.

  • NovoCure's Return on Sales fell 300.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.28% for FY2024, which is 1300.0% up from last year.
  • Per NovoCure's latest filing, its Return on Sales stood at 0.22% for Q3 2025, which was down 300.0% from 0.25% recorded in Q2 2025.
  • In the past 5 years, NovoCure's Return on Sales ranged from a high of 0.03% in Q1 2021 and a low of 0.46% during Q2 2023
  • For the 5-year period, NovoCure's Return on Sales averaged around 0.24%, with its median value being 0.22% (2024).
  • In the last 5 years, NovoCure's Return on Sales tumbled by -4000bps in 2023 and then surged by 2300bps in 2024.
  • NovoCure's Return on Sales (Quarter) stood at 0.2% in 2021, then crashed by -46bps to 0.29% in 2022, then dropped by -21bps to 0.35% in 2023, then fell by -16bps to 0.41% in 2024, then soared by 45bps to 0.22% in 2025.
  • Its Return on Sales was 0.22% in Q3 2025, compared to 0.25% in Q2 2025 and 0.22% in Q1 2025.